Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Alcohol-Mediated Renal Denervation Appears Safe for BP Reduction

Key clinical point: Delivered by injection, alcohol-based renal denervation was associated with efficacy and safety in pilot study.

Major finding: At six months, mean 24-hour ambulatory systolic blood pressure was reduced 11 mmHg.

Data Source: Open label study.

Disclosures: Dr. Sievert did not include Ablative Solutions, the developer of the Peregrine System Kit, on a list of pharmaceutical and device manufacturers with which he has financial relationships.

Citation:

2019 Cardiovascular Research Technologies.